GENENTECH

Related by string. Genentech * * Genentech Wyeth Pharmaceuticals . Roche Genentech . Avastin bevacizumab Genentech . Electronic Arts Genentech Genomic . Genentech Roche . collaborator Genentech . Roche Genentech Chugai . Lucentis ranibizumab Genentech . Squibb Genentech . Genentech Lucentis . Genentech Roche Chugai . Genentech Raptiva . bevacizumab Avastin Genentech *

Related by context. Frequent words. (Click for all words.) 74 THERAPEUTICS 73 LIFE SCIENCES 73 PHARM 71 INC. ANNOUNCES 71 TREATMENT OF 71 PRODUCTS AND 70 APPOINTS NEW 70 RESEARCH AND 70 SMARTREND 'S OPTION SCANNER 70 GROUP LTD 69 GROWTH IN THE 69 'S QUARTERLY RESULTS 69 CASINI 69 DETECTS BEARISH ENGULFING PATTERN 69 OUTLINES 69 INTEREST OF 69 DETECTS BULLISH HARAMI PATTERN 69 SUPPORT TO 69 PRICES GREAT DISCOUNTS 69 DECLINE IN 69 CULTURE AND 69 EARNINGS UPDATE 69 AND THOSE 69 DOWNWARD MOMENTUM LOOKS TO 69 THE TREND CONTINUES LOWER 69 'S SHARES CHANGING 69 RESEARCH AND DEVELOPMENT 69 TECHNOLOGIES INC 69 TRADING HIGHER ON #.#X 68 DETECTS BEARISH HARAMI PATTERN 68 TO STRENGTHEN 68 CAPABILITIES 68 ARE NOW 68 PHARMACEUTICALS 68 THE COURIER JOURNAL 68 SMARTREND RESEARCH REPORT AVAILABLE 68 THE TREND CONTINUES DOWN 68 MOVES INTO NEW 68 IN CONJUNCTION WITH 68 RESPOND TO 68 SHARES UP 68 RELEASES ITS QUARTERLY EARNINGS 67 DOWNTREND SPOTTED IN SHARES 67 INNOVATIONS 67 CHEAP ONLINE PHARMACY LOW 67 BREAKS THROUGH RESISTANCE AT 67 STATUS OF 67 AND MAKE 67 IS EXPECTED TO BEAT 67 DETECTS UNUSUAL ACTIVITY IN 67 LAUDS 67 HAS RETURNED 67 POTENTIALLY OVERVALUED IN TERMS 67 TO REGISTER 67 ASSOC 67 BREAKS THROUGH SUPPORT 67 PATTERN FOR 67 PERFORMANCE IN 67 SHARES DOWN 66 OUT IN SHARES 66 ON THE OCCASION 66 SMARTREND DETECTS 66 TO LAST QUARTER 66 HAS THE LOWEST 66 HAS THE HIGHEST 66 WHAT DO YOU LIKE 66 PFIZER 66 HOLDINGS INC 66 LOOKS TO CONTINUE TO 66 NEXT SUPPORT LEVEL FOR 66 ASSURANCE 66 SET TO PULLBACK AFTER 66 THE TREND CONTINUES UP 66 HAS MADE 66 WILL BE REPORTED IN 66 DAY TRADING RANGE 66 UPWARD MOMENTUM LOOKS TO 66 BIOTECH 66 THE HEALTH CARE 66 PRESENTATIONS 66 WEEK HIGH RECENTLY ECLIPSED 66 THE WINNING STREAK 66 TRADING RANGE BELOW 66 SEE CONTINUED DOWNWARD MOMENTUM 66 UPTREND SPOTTED IN SHARES 66 THE TREND CONTINUES HIGHER 66 APPLIED 66 APPROACHES NEW UPSIDE TARGET 66 SET TO POSSIBLY PULLBACK 66 STOCK ON 65 AGREES TO 65 WATCH FOR CONTINUED GAINS 65 STOCK TO WATCH 65 SMARTREND VINDICATED ON 65 RELATIONSHIP WITH 65 BULLISH MOVING AVERAGE CROSSOVER 65 Therapeutic Competitors 65 TRADING RANGE ABOVE 65 DAYS AGO 65 BEARISH MOVING AVERAGE CROSSOVER 65 SUCCESS FOR

Back to home page